Page last updated: 2024-08-23

cabergoline and Pregnancy

cabergoline has been researched along with Pregnancy in 150 studies

Research

Studies (150)

TimeframeStudies, this research(%)All Research%
pre-19903 (2.00)18.7374
1990's28 (18.67)18.2507
2000's41 (27.33)29.6817
2010's56 (37.33)24.3611
2020's22 (14.67)2.80

Authors

AuthorsStudies
Shi, H; Wu, D; Yu, T; Yu, Y; Zhai, J1
Karakus, C; Ozyurt, R; Turktekin, N1
Witwit, SJ1
Inder, WJ; Jang, C1
Bauersachs, J; Berliner, D; Erschow, S; Haebel, L; Hilfiker-Kleiner, D; Koenig, T; Mueller, JH; Pfeffer, TJ; Ricke-Hoch, M; Scherr, M; Talbot, SR; Yalman, KC; Zwadlo, C1
Hayashi, T; Higuchi, Y; Hirayama, A; Ichibori, Y; Iwai, S; Makino, N; Minamiguchi, H; Mitake, A; Mori, N; Shiba, M; Shibuya, Y1
Bruehlman, RD; McKittrick, C; Winters, S1
Auriemma, RS; Colao, A; Garifalos, F; Pirchio, R; Pivonello, C; Pivonello, R1
Cecenarro, LA; Fux-Otta, C; Murillo, NB; Ramacciotti, CF2
Miller, KK; Tritos, NA1
Blumenthal, PD; Cahill, EP; Henkel, A; Johnson, SA; Reeves, MF; Shaw, KA1
Atabay, F; Ateş, Ç; Dilbaz, B; Ergani, SY1
Farrant, MT; Gunn, AJ; Milsom, SR; O'Sullivan, SM; Ogilvie, CM1
Abucham, J; Boguszewski, CL; Bronstein, MD; Bueno, CB; Castro, M; Czepielewski, MA; Elias, PCL; Fontana, MLC; Francisco, RPV; Gadelha, MR; Garmes, HM; Glezer, A; Lyra, R; Marques, C; Martins, MRA; Musolino, NRC; Nazato, D; Nunes-Nogueira, VS; Portes, ES; Quidute, ARP; Ribeiro-Oliveira, A; Sant' Anna, BG; Vilar, L1
Baba, K; Hayashi, N; Huang, H; Ichinose, S; Itaya, Y; Matsunaga, S; Narita, T; Ono, Y; Saitoh, M; Samejima, K; Seki, H; Takai, Y1
Arce, JC; Bagger, YZ; Galliano, D; Herraiz, S; Pellicer, A; Pellicer, N1
Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD1
Biermasz, NR; Chanson, P; Jorgensen, JOL; Kuhn, E; Weinreich, AA1
Franchi, GA; Herskin, MS; Jensen, MB; Larsen, M; Tucker, CB1
Ach, K; Ach, T; Ben Abdelkrim, A; Chaieb, M; Elfekih, H; Hasni, Y; Kacem, M; Khaldi, S; Maaroufi, A; Saad, G1
Elshaer, HS; Farouk, M; Fouda, UM; Hanafy, A; Mehrem, WM; Nabil, H; Youssef, GG; Youssef, MA1
Abdelsalam, EA; Elmahdy, M; Maghraby, HA1
Amso, NN; D'Angelo, A; Hassan, R1
Araujo, B; Belo, S; Carvalho, D1
Deepak, DS; Lee, KO; Sek, KS1
Shimatsu, Y1
Bassiouny, YA; Bayoumi, YA; Dakhly, DMR; Gouda, HM; Hassan, AA; Salaheldin, NM1
Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G1
Hefzy, E; Seyam, E1
Celik, H; Celik, S; Hatirnaz, ES; Hatirnaz, S; Soyer-Calıskan, C; Tosun, M1
Ikeda, H; Tominaga, T; Watanabe, K; Yoshimoto, T1
Chen, HJ; Hsieh, BC; Huang, LW; Huang, MZ; Hwang, JL; Lin, YH; Seow, KM; Tzeng, CR1
Bai, CH; Chen, HJ; Hsieh, BC; Huang, LW; Hwang, JL; Lin, YH; Seow, KM; Tzeng, CR1
Bozdag, G; Esinler, I; Karakocsokmensuer, L1
Ehsanipoor, RM; Woo, I1
Andrés, M; Expósito, A; Matorras, R; Mendoza, R; Pijoan, JI; Prieto, B1
Abucham, J; Boguszewski, C; Dias, M; Gadelha, M; Kasuki, L; Musolino, N; Vieira, JG1
Leitao, VM; Martins, WP; Moroni, RM; Nastri, CO; Seko, LM1
Du, Y; Lin, XM; Ma, YS; Ni, J; Tang, YY; Zhou, J1
Figueroa-Núñez, C; González, E; Gutierrez, M; Hernán Martínez, J; Mangual-García, M; Mansilla-Letelier, P; Miranda, Mde L; Palermo-Garofalo, C; Sánchez, A; Santiago, M; Torres, O; Trinidad, R1
Bronstein, MD; Glezer, A1
Schäfer-Somi, S; Schwendenwein, I; Sontas, BH1
Eglash, A1
Angelova, M; Kacarova, P; Kozovski, G1
Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA1
Couldwell, WT; Eloy, JA; Liu, JK; Wong, A1
Apaydın, N; Cengiz, H; Eskicioğlu, F; Genç, M; Şahin, N; Sivrikoz, ON; Töz, E; Turan, GA1
Elsetohy, KA; Elshaer, HS; Fouda, UM; Hammad, BE; Sayed, AM; Shaban, MM; Youssef, MA1
Ahmad, MS; Nakhleh, A; Pearl, IW; Reut, M; Saiegh, L; Shechner, C1
Araujo Júnior, E; Carvalho, JS; Carvalho, RC; Costa Carvalho, FH; Feitosa, FE; Melo, MA; Peixoto, AB1
Fett, JD1
Beshyah, SA; Chentli, F; El-Fikki, M; Hamrahian, A; Jambart, S; Khalil, AB; Raef, H; Sherif, IH1
Hart, RJ; Mourad, S; Tang, H; Zhai, SD1
Bhadada, SK; Bhansali, A; Rastogi, A1
Dhanjal, MK; Knight, M; Lambert, K; McCance, DR; Rees, K; Seed, PT; Williamson, C1
Brown, J; Farquhar, C; Mourad, S1
Banerjee, A; Hatfield, EC; Martin, NM; Meeran, K; Tan, T; Williamson, C; Wynne, K1
Jin, ZM1
Acharya, SV; Bandgar, TR; Gopal, RA; Joshi, SR; Menon, PS; Shah, NS1
Bouma, BJ; de Jong, JS; Rietveld, K; van Lochem, LT1
Kharlip, J; Salvatori, R; Wand, GS; Yenokyan, G1
England, GC; Freeman, SL; Russo, M1
Ballabio, R; Gelli, D; Milani, C; Mollo, A; Perin, S; Romagnoli, S; Stelletta, C1
Arias, D; Barrena, JP; Blanco, PG; Corrada, Y; Gobello, C; Rube, A1
Einspanier, A; Günzel-Apel, AR; Höftmann, T; Hoppen, HO; Knijn, HM; Meyer-Lindenberg, A; Mischke, R; Nottorf, S; Politt, E1
Albuquerque, JL; Azevedo, MF; Boguszewski, CL; Bronstein, MD; Casulari, LA; de Oliveira, AR; Dos Santos Faria, M; Gadelha, MR; Montenegro, RM; Musolino, NR; Naves, LA; Pinho Barbosa, FR; Ramos, AJ; Serfaty, FM; Vilar, L1
Boissevain, I1
Amano, K; Hori, T; Izumi, S; Kawamata, T; Makino, R; Miki, N; Okada, Y; Ono, M; Seki, T; Takano, K1
Klibanski, A1
Marinov, B1
Arioz, DT; Dilek, H; Koken, T; Saylan, A; Saylan, F; Yilmazer, M1
Bernard, P; Hubinont, C; Lebbe, M; Maiter, D1
Bahceci, M; Sismanoglu, A; Ulug, U1
Molitch, ME2
Alfieri, A; Ballarino, MC; Boero, L; Chervin, A; Danilowicz, K; Diez, S; Fainstein-Day, P; García-Basavilbaso, N; Glerean, M; Gollan, V; Guitelman, M; Katz, D; Loto, MG; Mallea-Gil, MS; Manavela, M; Rogozinski, AS; Servidio, M; Stalldecker, G; Vitale, NM1
Bourdel, N; Delabaere, A; Jardon, K; Pouly, JL; Tran, X1
Agaoglu, AR; Aslan, S; Colak, A; Emre, B; Gultiken, N; Kaya, D; Kucukaslan, I; Mulazımoglu, BS; Schäfer-Somi, S1
Akutsu, H; Matsumura, A; Sato, H; Takano, S; Watanabe, S1
Arabipoor, A; Aziminekoo, E; Bahmanabadi, A; Chehrazi, M; Hafezi, M; Tehraninejad, ES1
Hart, RJ; Hu, Y; Hunter, T; Sheng, X; Tang, H; Zhai, SD1
Maiter, D; Primeau, V1
Nak, D; Nak, Y; Simsek, G1
Berardini, A; Biagini, E; Graziosi, M; Pazzi, C; Rapezzi, C; Rosmini, S1
Peregrin Abad, E; Salinas Botrán, A; Urgelés Puértolas, D1
Shaltout, A; Shohyab, A; Youssef, MA1
Shahzad, H; Sheikh, A; Sheikh, L1
Auriemma, RS; Colao, A; Di Sarno, A; Gasperi, M; Grasso, LF; Guerra, E; Perone, Y; Pivonello, R1
Liu, C; Tyrrell, JB1
DeLiberto, TJ; Jöchle, W; Kimball, B; Seglund, A1
Calda, P; Pavlista, D; Zivný, J1
Gabai, G; Marinelli, L; Mollo, A; Rota, A; Vincenti, L1
Arbeiter, K; Aslan, S; Erünal-Maral, N; Findik, M; Handler, J; Yüksel, N1
Couldwell, WT; Liu, JK1
Trifonov, I1
Brooks, PL; Vella, ET; Wynne-Edwards, KE1
Abs, R; Verhelst, J1
Adamo, V; Manno, M; Marchesan, E; Tomei, F1
Crosignani, PG1
Bronstein, MD1
Günzel-Apel, AR; Hoeftmann, T; Meyer-Lindenberg, A; Politt, E; Schoon, HA; Steiger, K1
Kanzato, N; Murao, H; Nishihira, T; Takara, H1
Ak, K; Bacinoglu, S; Cangul, IT; Cirit, U; Kaya, HH; Taş, M1
Alvarez, C; Fernández-Sánchez, M; Gómez, R; Martí-Bonmatí, L; Novella-Maestre, E; Pellicer, A; Sanz, R; Simón, C1
Ciraru-Vigneron, N; Laloi-Michelin, M; Meas, T1
Aboulghar, MA1
Aksoy, OA; Aslan, S; Beceriklisoy, HB; Einspanier, A; Hoppen, HO; Schäfer-Somi, S1
Abs, R; Bárcena, DG; Chanson, P; Colao, A; Kleinberg, DL; Paulus, W1
Alonso-Muriel, I; Alvarez, C; Bellver, J; Crespo, J; García, G; Pellicer, A; Simón, C1
Bevan, JS; Davis, JR1
Ciccarelli, E; D'Alberton, A; Falsetti, L; Ferrari, C; Fioretti, P; Giordano, G; L'Hermite, M; Piscitelli, G; Polli, A; Webster, J1
Donnay, I; Onclin, K; Silva, LD; Verstegen, JP2
Fraser, RB; Jones, TH1
Ajossa, S; Depau, GF; Guerriero, S; Mais, V; Melis, GB; Paoletti, AM1
Delahaut, P; Ectors, F; Onclin, K; Silva, LD; Verstegen, JP; Wouters-Ballman, P1
Jöchle, M; Jöchle, W1
Delgrange, E; Donckier, J; Maiter, D1
Webster, J3
Onclin, K; Verstegen, JP2
Koide, SS; Negishi, H1
Jeukenne, P; Verstegen, J1
Onclin, K; Verstegen, J1
Arosio, M; Biella, O; Faglia, G; Gambino, G; Muratori, M; Romano, C1
Bertagna, A; Camanni, F; Camanni, M; Cammarota, T; Ciccarelli, E; Cirillo, S; Gaia, D; Grottoli, S; Razzore, P1
Armentano, G; Bracco, PL; Pellegrini, A; Sugliano, GC; Tornatore, GP1
Hettling, P1
Hearn, CM; Renfree, MB; Shaw, G; Short, RV1
Krack, P; Mönig, H1
Almoto, B; Cannavò, S; Curtò, L; Squadrito, S; Trimarchi, F; Vieni, A1
Abs, R; Beckers, A; Coremans, P; Lamberigts, G; Mahler, C; Maiter, D; Mockel, J; Petrossians, P; Raftopoulos, C; Stevenaert, A; van den Bruel, A; Vandeweghe, M; Velkeniers, B; Verhelst, J; Verlooy, J1
Abs, R; Berwaerts, J; Mahler, C; Verhelst, J1
Concannon, PW; Onclin, K; Silva, LD; Verstegen, JP1
Annunziato, L; Colao, A; Lombardi, G1
Jalkanen, L; Marks, CA; Savolainen, R; Short, RV1
De Santis, L; Doldi, N; Ferrari, A; Marelli, G; Marsiglio, E; Papaleo, E; Rofena, S1
Bozhinova, S; Penkov, V; Porozhanova, V1
Jöchle, W; Lengwinat, T; Meyer, HH1
Marks, CA1
Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R1
Castex, G; Corrada, Y; Gobello, C1
Brzozowski, M; Clark, M; Marks, CA; Zurek, H1
Arbeiter, K; Ballabio, R; D'Ver, AS; Jöchle, W; Post, K1
Beneventi, F; Fioretti, P; Gambacciani, M; Mais, V; Melis, GB; Paoletti, AM1
Baroldi, P; Beneventi, F; Fioretti, P; Gambacciani, M; Mais, V; Melis, GB; Paoletti, AM1

Reviews

29 review(s) available for cabergoline and Pregnancy

ArticleYear
Comparison of the Effectiveness of Various Medicines in the Prevention of Ovarian Hyperstimulation Syndrome: A Network Meta-Analysis of Randomized Controlled Trials.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Cabergoline; Female; Humans; Network Meta-Analysis; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic

2022
Treatment of Prolactinoma.
    Medicina (Kaunas, Lithuania), 2022, Aug-13, Volume: 58, Issue:8

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactinoma; Treatment Outcome

2022
Approach to the Patient With Prolactinoma.
    The Journal of clinical endocrinology and metabolism, 2023, 08-18, Volume: 108, Issue:9

    Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma

2023
Diagnosis and Management of Pituitary Adenomas: A Review.
    JAMA, 2023, 04-25, Volume: 329, Issue:16

    Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Child; Female; Human Growth Hormone; Humans; Hypopituitarism; Pituitary Neoplasms; Pregnancy; Prolactinoma

2023
Use of dopamine agonists to target angiogenesis in women with endometriosis.
    Human reproduction (Oxford, England), 2021, 03-18, Volume: 36, Issue:4

    Topics: Cabergoline; Dopamine Agonists; Endometriosis; Endometrium; Female; Humans; Pregnancy; Vascular Endothelial Growth Factor A

2021
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2021, 04-14, Volume: 4

    Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic

2021
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature.
    European journal of endocrinology, 2021, May-24, Volume: 185, Issue:1

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Tumor Burden; Young Adult

2021
Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2017, 05-23, Volume: 5

    Topics: Abortion, Spontaneous; Cabergoline; Chorionic Gonadotropin; Ergolines; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Pregnancy, Multiple; Randomized Controlled Trials as Topic; Withholding Treatment

2017
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome
    Acta clinica Croatica, 2017, Volume: 56, Issue:1

    Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate

2017
Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials.
    Fertility and sterility, 2014, Volume: 101, Issue:3

    Topics: Cabergoline; Ergolines; Female; Humans; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted

2014
Prolactinomas, cabergoline, and pregnancy.
    Endocrine, 2014, Volume: 47, Issue:1

    Topics: Animals; Antineoplastic Agents; Cabergoline; Ergolines; Female; Fetal Development; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactinoma

2014
Update on prolactinomas. Part 2: Treatment and management strategies.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2015, Volume: 22, Issue:10

    Topics: Bromocriptine; Cabergoline; Disease Management; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuroendoscopy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Sphenoid Sinus

2015
Dopamine agonists for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2016, 11-30, Volume: 11

    Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted

2016
Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.
    The Cochrane database of systematic reviews, 2017, 01-23, Volume: 1

    Topics: Cabergoline; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Metformin; Ovarian Hyperstimulation Syndrome; Pregnancy; Progesterone; Reproductive Techniques, Assisted; Review Literature as Topic

2017
Clinical practice. Prolactinomas.
    The New England journal of medicine, 2010, Apr-01, Volume: 362, Issue:13

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Visual Fields

2010
Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature.
    Pituitary, 2010, Volume: 13, Issue:4

    Topics: Adult; Cabergoline; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Gestational Age; Humans; Hyperprolactinemia; Middle Aged; Pregnancy; Pregnancy Complications; Premature Birth; Prolactin; Retrospective Studies; Young Adult

2010
Prolactinoma in pregnancy.
    Best practice & research. Clinical endocrinology & metabolism, 2011, Volume: 25, Issue:6

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fetus; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma

2011
Cabergoline for preventing ovarian hyperstimulation syndrome.
    The Cochrane database of systematic reviews, 2012, Feb-15, Issue:2

    Topics: Abortion, Spontaneous; Administration, Oral; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted

2012
2012 update in the treatment of prolactinomas.
    Annales d'endocrinologie, 2012, Volume: 73, Issue:2

    Topics: Cabergoline; Contraindications; Dopamine Agonists; Endocrinology; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma

2012
Contemporary management of prolactinomas.
    Neurosurgical focus, 2004, Apr-15, Volume: 16, Issue:4

    Topics: Bromocriptine; Cabergoline; Contraindications; Diagnosis, Differential; Ergolines; Female; Humans; Hypophysectomy; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Remission Induction

2004
[Prolactinoma and pregnancy].
    Akusherstvo i ginekologiia, 2004, Volume: 43 Suppl 2

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma

2004
Hyperprolactinemia: pathophysiology and management.
    Treatments in endocrinology, 2003, Volume: 2, Issue:1

    Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative

2003
Current treatment issues in female hyperprolactinaemia.
    European journal of obstetrics, gynecology, and reproductive biology, 2006, Apr-01, Volume: 125, Issue:2

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma

2006
Prolactinomas and pregnancy.
    Pituitary, 2005, Volume: 8, Issue:1

    Topics: Aminoquinolines; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma

2005
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Drug safety, 1996, Volume: 14, Issue:4

    Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Male; Pregnancy

1996
Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999, Volume: 13, Issue:3

    Topics: Adult; Cabergoline; Cushing Syndrome; Dopamine Agonists; Ergolines; Female; Humans; Ketoconazole; Pregnancy; Pregnancy Complications; Pregnancy Outcome

1999
Clinical management of prolactinomas.
    Bailliere's best practice & research. Clinical endocrinology & metabolism, 1999, Volume: 13, Issue:3

    Topics: Bone Density; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma

1999
Bait-delivered cabergoline for the reproductive control of the red fox (Vulpes vulpes): estimating mammalian non-target risk in south-eastern Australia.
    Reproduction, fertility, and development, 2001, Volume: 13, Issue:7-8

    Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Animals; Australia; Cabergoline; Embryo Implantation; Ergolines; Female; Foxes; Lactation; Mammals; Population Control; Pregnancy; Prolactin; Reproduction

2001
Dopamine receptor agonists for treating prolactinomas.
    Expert opinion on investigational drugs, 2002, Volume: 11, Issue:6

    Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma

2002

Trials

32 trial(s) available for cabergoline and Pregnancy

ArticleYear
Cabergoline for Lactation Inhibition After Second-Trimester Abortion or Pregnancy Loss: A Randomized Controlled Trial.
    Obstetrics and gynecology, 2023, 06-01, Volume: 141, Issue:6

    Topics: Abortion, Induced; Abortion, Spontaneous; Cabergoline; Double-Blind Method; Female; Humans; Infant; Lactation; Pregnancy; Pregnancy Trimester, Second; Prolactin

2023
Cabergoline versus calcium infusion in the prevention of ovarian hyperstimulation syndrome: a randomised controlled study.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2022, Volume: 42, Issue:1

    Topics: Adult; Cabergoline; Calcium Gluconate; Female; Fertilization in Vitro; Humans; Incidence; Infusions, Intravenous; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Single-Blind Method; Treatment Outcome

2022
Randomized trial of combined cabergoline and coasting in preventing ovarian hyperstimulation syndrome during in vitro fertilization/intracytoplasmic sperm injection cycles.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2018, Volume: 140, Issue:2

    Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Sperm Injections, Intracytoplasmic

2018
Laparoscopic ovarian drilling versus GnRH antagonist combined with cabergoline as a prophylaxis against the re-development of ovarian hyperstimulation syndrome.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2018, Volume: 34, Issue:7

    Topics: Adult; Cabergoline; Chemoprevention; Clomiphene; Drug Resistance; Ergolines; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gynecologic Surgical Procedures; Hormone Antagonists; Humans; Infertility, Female; Laparoscopy; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Secondary Prevention; Treatment Failure

2018
Clinical outcome according to timing of cabergoline initiation for prevention of OHSS: a randomized controlled trial.
    Reproductive biomedicine online, 2013, Volume: 26, Issue:6

    Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Treatment Outcome

2013
Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch.
    European journal of obstetrics, gynecology, and reproductive biology, 2013, Volume: 170, Issue:2

    Topics: Adult; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Hydroxyethyl Starch Derivatives; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Plasma Substitutes; Pregnancy; Pregnancy Rate; Prospective Studies; Secondary Prevention; Triptorelin Pamoate

2013
Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.
    Archives of gynecology and obstetrics, 2016, Volume: 293, Issue:5

    Topics: Animals; Cabergoline; Capillary Permeability; Chorionic Gonadotropin; Ergolines; Eye Proteins; Female; Gonadotropins, Equine; Humans; Letrozole; Nerve Growth Factors; Nitriles; Ovarian Hyperstimulation Syndrome; Ovary; Pregnancy; Prospective Studies; Rats; Rats, Wistar; Serpins; Triazoles; Vascular Endothelial Growth Factor A

2016
GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial.
    Journal of ovarian research, 2016, May-17, Volume: 9, Issue:1

    Topics: Adult; Antineoplastic Agents; Cabergoline; Chorionic Gonadotropin; Ergolines; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Incidence; Outcome Assessment, Health Care; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Young Adult

2016
Follicular dynamics, ovulation and conception rates in bitches.
    Reproduction in domestic animals = Zuchthygiene, 2009, Volume: 44 Suppl 2

    Topics: Animals; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Estrous Cycle; Female; Fertilization; Gonadotropins; Male; Ovarian Follicle; Ovulation; Pregnancy

2009
Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches.
    Reproduction in domestic animals = Zuchthygiene, 2009, Volume: 44 Suppl 2

    Topics: Animals; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Female; Lactation; Postpartum Period; Pregnancy; Prolactin; Time Factors

2009
The intravaginal application of misoprostol improves induction of abortion with aglepristone.
    Theriogenology, 2011, Jul-01, Volume: 76, Issue:1

    Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Animals; Cabergoline; Cloprostenol; Dogs; Ergolines; Estrenes; Estrogens; Female; Misoprostol; Pregnancy; Progesterone; Time Factors

2011
Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial.
    Journal of assisted reproduction and genetics, 2012, Volume: 29, Issue:3

    Topics: Adult; Cabergoline; Dopamine Agents; Ergolines; Female; Fertilization in Vitro; Humans; Incidence; Infertility; Infusions, Intravenous; Iran; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Risk Factors; Serum Albumin; Serum Albumin, Human; Severity of Illness Index; Sperm Injections, Intracytoplasmic; Young Adult

2012
Can dopamine agonist at a low dose reduce ovarian hyperstimulation syndrome in women at risk undergoing ICSI treatment cycles? A randomized controlled study.
    European journal of obstetrics, gynecology, and reproductive biology, 2012, Volume: 165, Issue:2

    Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Sperm Injections, Intracytoplasmic

2012
[Arrest of lactation after 2nd trimester abortion with a single dose of cabergoline in comparison with 10-day administration of teguride].
    Ceska gynekologie, 2003, Volume: 68, Issue:1

    Topics: Abortion, Induced; Adolescent; Adult; Cabergoline; Drug Administration Schedule; Ergolines; Female; Humans; Lactation; Lisuride; Pregnancy; Pregnancy Trimester, Second; Prospective Studies

2003
Evaluation of cabergoline and buserelin efficacy for oestrous induction in the bitch.
    Reproduction in domestic animals = Zuchthygiene, 2003, Volume: 38, Issue:6

    Topics: Administration, Oral; Animals; Buserelin; Cabergoline; Dogs; Drug Administration Schedule; Ergolines; Estrus; Female; Fertility Agents, Female; Injections, Subcutaneous; Pregnancy; Prolactin; Treatment Outcome

2003
Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?
    European journal of obstetrics, gynecology, and reproductive biology, 2005, Sep-01, Volume: 122, Issue:1

    Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Treatment Outcome

2005
Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:8

    Topics: Adult; Ascites; Cabergoline; Dopamine Agonists; Double-Blind Method; Ergolines; Extracellular Space; Female; Fertilization in Vitro; Granulosa Cells; Hematocrit; Hemoglobins; Humans; Image Processing, Computer-Assisted; Luteal Cells; Magnetic Resonance Imaging; Ovarian Hyperstimulation Syndrome; Ovary; Pregnancy; Prospective Studies; Receptors, Dopamine D2; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction

2007
Repeated induction of abortion in bitches and the effect on plasma concentrations of relaxin, progesterone and estradiol-17beta.
    Theriogenology, 2007, Oct-01, Volume: 68, Issue:6

    Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Animals; Cabergoline; Dogs; Drug Combinations; Ergolines; Estradiol; Estrenes; Female; Pregnancy; Progesterone; Relaxin

2007
Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study.
    Clinical endocrinology, 2008, Volume: 68, Issue:1

    Topics: Abortion, Spontaneous; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pregnancy; Pregnancy Outcome; Prospective Studies

2008
The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group.
    Clinical endocrinology, 1993, Volume: 39, Issue:3

    Topics: Adult; Cabergoline; Dopamine Agents; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Pregnancy; Prospective Studies; Time Factors

1993
Luteotrophic action of prolactin in dogs and the effects of a dopamine agonist, cabergoline.
    Journal of reproduction and fertility. Supplement, 1993, Volume: 47

    Topics: Abortifacient Agents; Abortion, Induced; Animals; Cabergoline; Corpus Luteum Maintenance; Dog Diseases; Dogs; Dopamine Agents; Ergolines; Female; Fetal Resorption; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin

1993
Abortion induction in the cat using prostaglandin F2 alpha and a new anti-prolactinic agent, cabergoline.
    Journal of reproduction and fertility. Supplement, 1993, Volume: 47

    Topics: Abortifacient Agents; Abortion, Induced; Animals; Cabergoline; Cats; Dinoprost; Drug Evaluation; Ergolines; Female; Fetal Resorption; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin

1993
Reproduction in a feral cat population and its control with a prolactin inhibitor, cabergoline.
    Journal of reproduction and fertility. Supplement, 1993, Volume: 47

    Topics: Abortifacient Agents; Abortion, Induced; Animals; Animals, Wild; Cabergoline; Cats; Dog Diseases; Dogs; Ergolines; Female; Fertility; Male; Mammary Glands, Animal; Obstetric Labor, Premature; Pregnancy; Pregnancy, Animal; Prolactin; Reproduction

1993
Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine.
    European journal of endocrinology, 1996, Volume: 134, Issue:4

    Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactinoma

1996
Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients.
    Journal of endocrinological investigation, 1997, Volume: 20, Issue:9

    Topics: Acromegaly; Adenoma; Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin-Like Growth Factor I; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin

1997
[Cabergoline in the inhibition of lactogenesis and suppression of lactopoiesis].
    Minerva ginecologica, 1997, Volume: 49, Issue:10

    Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Infant, Newborn; Lactation; Pregnancy; Prolactin; Puerperal Disorders

1997
Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma.
    Journal of endocrinological investigation, 1999, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Cabergoline; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin; Prolactinoma; Treatment Outcome

1999
Control of red fox (Vulpes vulpes) fertility with cabergoline: dose response and timing of intervention.
    Reproduction (Cambridge, England), 2001, Volume: 122, Issue:1

    Topics: Abortion, Induced; Abortion, Veterinary; Animals; Animals, Newborn; Cabergoline; Dose-Response Relationship, Drug; Ergolines; Female; Foxes; Gestational Age; Lactation; Litter Size; Placebos; Pregnancy; Time Factors

2001
Effectiveness of cabergoline for termination of pregnancy in silver fox (Vulpes vulpes fulva).
    Reproduction in domestic animals = Zuchthygiene, 2001, Volume: 36, Issue:5

    Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Administration, Oral; Animals; Cabergoline; Dose-Response Relationship, Drug; Ergolines; Female; Foxes; Pregnancy; Progesterone; Prolactin

2001
Control of fertility in the red fox (Vulpes vulpes): effect of a single oral dose of cabergoline in early pregnancy.
    Reproduction, fertility, and development, 2002, Volume: 14, Issue:1-2

    Topics: Abortion, Induced; Abortion, Veterinary; Administration, Oral; Animals; Cabergoline; Dopamine Agonists; Ecosystem; Ergolines; Female; Fertility; Foxes; Litter Size; Male; Population Control; Pregnancy; Pregnancy, Animal

2002
Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition.
    BMJ (Clinical research ed.), 1991, Jun-08, Volume: 302, Issue:6789

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Double-Blind Method; Drug Administration Schedule; Ergolines; Female; Humans; Lactation; Pregnancy; Prospective Studies

1991
Prevention of puerperal lactation by a single oral administration of the new prolactin-inhibiting drug, cabergoline.
    Obstetrics and gynecology, 1988, Volume: 71, Issue:3 Pt 1

    Topics: Administration, Oral; Adult; Cabergoline; Clinical Trials as Topic; Ergolines; Female; Humans; Lactation; Postpartum Period; Pregnancy; Prolactin; Random Allocation

1988

Other Studies

89 other study(ies) available for cabergoline and Pregnancy

ArticleYear
Calcium gluconate infusion is not as effective as dopamine agonists in preventing ovarian hyperstimulation syndrome.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:4

    Topics: Cabergoline; Calcium Gluconate; Dopamine Agonists; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate

2022
Improving pregnancy rate in infertile patients with polycystic ovarian syndrome receiving clomiphene citrate and cabergoline in euprolactinomic women in single cycle treatment.
    Ginekologia polska, 2023, Volume: 94, Issue:6

    Topics: Cabergoline; Clomiphene; Female; Humans; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Prolactin; Prospective Studies

2023
Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    ESC heart failure, 2023, Volume: 10, Issue:1

    Topics: Animals; Bromocriptine; Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Heart Failure; Mice; MicroRNAs; Myocytes, Cardiac; Peripartum Period; Pregnancy; Prolactin; Ventricular Dysfunction, Left

2023
Peripartum Cardiomyopathy with the Cardiac Function Restored by Cabergoline.
    Internal medicine (Tokyo, Japan), 2023, Jul-15, Volume: 62, Issue:14

    Topics: Adult; Cabergoline; Cardiomyopathies; Cesarean Section; Female; Heart Failure; Humans; Peripartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders

2023
Galactorrhea: Rapid Evidence Review.
    American family physician, 2022, Volume: 106, Issue:6

    Topics: Cabergoline; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin

2022
Cushing's disease in pregnancy and treatment with cabergoline: obstetric and neonatal results
    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2023, 03-31, Volume: 80, Issue:1

    Topics: Cabergoline; Colectomy; Female; Humans; Pituitary ACTH Hypersecretion; Pregnancy; Retrospective Studies; Tretinoin

2023
    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 2023, Mar-31, Volume: 80, Issue:1

    Topics: Cabergoline; Colectomy; Female; Humans; Pituitary ACTH Hypersecretion; Pregnancy; Retrospective Studies; Tretinoin

2023
Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats.
    Revista da Associacao Medica Brasileira (1992), 2023, Volume: 69, Issue:11

    Topics: Animals; Body Weight; Cabergoline; Female; Horses; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Rats; Rats, Wistar; Vascular Endothelial Growth Factor A

2023
An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2020, Volume: 60, Issue:3

    Topics: Abortion, Spontaneous; Adenoma; Adolescent; Adult; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Female; Humans; Infertility; Lactation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult

2020
A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas.
    Pituitary, 2020, Volume: 23, Issue:2

    Topics: Abortion, Spontaneous; Adolescent; Adult; Aged; Cabergoline; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Retrospective Studies; Young Adult

2020
Late-onset ovarian hyperstimulation syndrome developing during ovarian stimulation in an ectopic pregnancy: a case report.
    Journal of medical case reports, 2020, Jul-20, Volume: 14, Issue:1

    Topics: Adult; Cabergoline; Chorionic Gonadotropin; Estradiol; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy, Ectopic

2020
Assessing effects of dietary and milking frequency changes and injection of cabergoline during dry-off on hunger in dairy cows using 2 feed-thwarting tests.
    Journal of dairy science, 2021, Volume: 104, Issue:9

    Topics: Animal Feed; Animals; Cabergoline; Cattle; Dairying; Diet; Female; Hunger; Lactation; Milk; Pregnancy

2021
Pituitary apoplexy of a giant prolactinoma during pregnancy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2021, Volume: 37, Issue:9

    Topics: Adult; Cabergoline; Cytoreduction Surgical Procedures; Fatal Outcome; Female; Humans; Infertility; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Twin; Premature Birth; Prolactin; Prolactinoma

2021
Combining several interventions to reduce the incidence of OHSS: A prospective cohort study.
    European journal of obstetrics, gynecology, and reproductive biology, 2017, Volume: 212

    Topics: Adult; Aspirin; Cabergoline; Chorionic Gonadotropin; Drug Therapy, Combination; Ergolines; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Reproductive Control Agents; Severity of Illness Index

2017
Pregnancy and Tumor Outcomes in Women with Prolactinoma.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2017, Volume: 125, Issue:10

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Outcome Assessment, Health Care; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult

2017
Use of cabergoline for the management of persistent Cushing's disease in pregnancy.
    BMJ case reports, 2017, Jul-14, Volume: 2017

    Topics: Adult; Antineoplastic Agents; Cabergoline; Diagnosis, Differential; Ergolines; Female; Humans; Pituitary ACTH Hypersecretion; Pregnancy; Pregnancy Complications; Prenatal Diagnosis; Recurrence; Remission Induction

2017
Use of cabergoline for oestrus induction in multiparous anoestrous Beagle bitches.
    Australian veterinary journal, 2017, Volume: 95, Issue:9

    Topics: Anestrus; Animals; Breeding; Cabergoline; Dogs; Ergolines; Estrus; Female; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone

2017
Lifesaving dose increment of cabergoline in life-threatening spontaneous ovarian hyperstimulation syndrome resistant to all interventions.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2019, Volume: 35, Issue:4

    Topics: Adult; Cabergoline; Dopamine Agonists; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Complications

2019
Transsphenoidal microsurgical results of female patients with prolactinomas.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:9

    Topics: Adult; Cabergoline; Cavernous Sinus; Dopamine Agonists; Endoscopy; Ergolines; Female; Humans; Magnetic Resonance Imaging; Microsurgery; Neoplasm Recurrence, Local; Neurosurgical Procedures; Pituitary Neoplasms; Postoperative Complications; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Sphenoid Bone; Treatment Outcome

2013
Combination of cabergoline and embryo cryopreservation after GnRH agonist triggering prevents OHSS in patients with extremely high estradiol levels--a retrospective study.
    Journal of assisted reproduction and genetics, 2013, Volume: 30, Issue:6

    Topics: Adult; Cabergoline; Cryopreservation; Embryo Transfer; Ergolines; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Retrospective Studies; Sperm Injections, Intracytoplasmic

2013
Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting.
    Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:5

    Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Hormones; Humans; Infertility, Female; Leuprolide; Longitudinal Studies; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Retrospective Studies; Young Adult

2013
Cabergoline therapy for Cushing disease throughout pregnancy.
    Obstetrics and gynecology, 2013, Volume: 122, Issue:2 Pt 2

    Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Infant, Newborn; Live Birth; Pituitary ACTH Hypersecretion; Pregnancy; Pregnancy Complications

2013
Acromegaly and pregnancy: a prospective study.
    European journal of endocrinology, 2014, Volume: 170, Issue:2

    Topics: Acromegaly; Adult; Cabergoline; Ergolines; Female; Human Growth Hormone; Humans; Infant, Newborn; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Octreotide; Pregnancy; Pregnancy Complications, Neoplastic; Prospective Studies; Sella Turcica

2014
Relaxant effects of metoclopramide and magnesium sulfate on isolated pregnant myometrium: an in vitro study.
    International journal of obstetric anesthesia, 2014, Volume: 23, Issue:2

    Topics: Adult; Cabergoline; Dopamine Agonists; Dopamine Antagonists; Ergolines; Female; Humans; In Vitro Techniques; Magnesium Sulfate; Metoclopramide; Muscle Relaxation; Myometrium; Oxytocin; Pregnancy; Tocolytic Agents; Uterine Contraction

2014
Young female with acromegaloid features and pituitary macroadenoma: what is your diagnosis?
    Boletin de la Asociacion Medica de Puerto Rico, 2014, Volume: 106, Issue:1

    Topics: Acanthosis Nigricans; Acromegaly; Adult; Bromocriptine; Cabergoline; Diagnosis, Differential; Ergolines; Female; Gastrointestinal Diseases; Hirsutism; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prognathism; Prolactinoma

2014
Primary anestrus due to dietary hyperthyroidism in a miniature pinscher bitch.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2014, Volume: 55, Issue:8

    Topics: Administration, Oral; Anestrus; Animal Feed; Animals; Cabergoline; Diagnosis, Differential; Dog Diseases; Dogs; Ergolines; Female; Humans; Hyperthyroidism; Pedigree; Pregnancy; Pregnancy, Animal; Thyroxine

2014
Treatment of maternal hypergalactia.
    Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2014, Volume: 9, Issue:9

    Topics: Adult; Breast Feeding; Breast Milk Expression; Cabergoline; Ergolines; Estrogens; Feeding Behavior; Female; Homeopathy; Humans; Infant, Newborn; Lactation Disorders; Nasal Decongestants; Pregnancy; Prolactin; Pseudoephedrine; Severity of Illness Index

2014
[Use of cabergoline for prevention of ovarian hyperstimulation syndrome in assisted reproductive technologies].
    Akusherstvo i ginekologiia, 2014, Volume: 53, Issue:5

    Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Pregnancy

2014
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2015, Volume: 62, Issue:4

    Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders

2015
Cabergoline treatment for recurrent Cushing's disease during pregnancy.
    Hormones (Athens, Greece), 2016, Volume: 15, Issue:3

    Topics: Adult; Antineoplastic Agents; Biomarkers; Cabergoline; Ergolines; Female; Humans; Hydrocortisone; Live Birth; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Pituitary ACTH Hypersecretion; Pregnancy; Pregnancy Complications; Remission Induction; Treatment Outcome

2016
Peripartum Cardiomyopathy Treatment with Dopamine Agonist and Subsequent Pregnancy with a Satisfactory Outcome.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016, Volume: 38, Issue:6

    Topics: Adolescent; Cabergoline; Cardiomyopathies; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Puerperal Disorders

2016
Cabergoline in the Treatment of Peripartum Cardiomyopathy.
    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2016, Volume: 38, Issue:8

    Topics: Cabergoline; Cardiomyopathies; Dopamine Agonists; Female; Humans; Peripartum Period; Pregnancy; Puerperal Disorders

2016
Management of prolactinomas: a survey of physicians from the Middle East and North Africa.
    Pituitary, 2017, Volume: 20, Issue:2

    Topics: Adult; Africa, Northern; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Middle East; Physicians; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Surveys and Questionnaires

2017
Pregnancy and tumor outcomes in infertile women with macroprolactinoma on cabergoline therapy.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:4

    Topics: Adult; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Treatment Outcome; Young Adult

2017
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
    Obstetrics and gynecology, 2017, Volume: 129, Issue:1

    Topics: Adenoma; Adult; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cesarean Section; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Incidence; Pituitary Neoplasms; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Premature Birth; Prolactinoma; Prospective Studies; Stillbirth; United Kingdom; Vision Disorders; Young Adult

2017
High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.
    Clinical endocrinology, 2009, Volume: 70, Issue:5

    Topics: Adult; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma

2009
[Some issues in the diagnosis and treatment of hyperprolactinemia].
    Zhonghua fu chan ke za zhi, 2008, Volume: 43, Issue:4

    Topics: Aminoquinolines; Cabergoline; Diagnosis, Differential; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma

2008
Clinical profile and long term follow up of children and adolescents with prolactinomas.
    Pituitary, 2009, Volume: 12, Issue:3

    Topics: Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Male; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult

2009
Rapid left ventricular recovery after cabergoline treatment in a patient with peripartum cardiomyopathy.
    European journal of heart failure, 2009, Volume: 11, Issue:2

    Topics: Adult; Cabergoline; Cardiomyopathies; Echocardiography; Ergolines; Female; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Pregnancy; Prolactin; Puerperal Disorders; Ventricular Dysfunction, Left

2009
Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Prolactinoma; Recurrence; Retrospective Studies; Time Factors; Withholding Treatment; Young Adult

2009
An experimental model to study resistance index and systolic/diastolic ratio of uterine arteries in adverse canine pregnancy outcome.
    Reproduction in domestic animals = Zuchthygiene, 2009, Volume: 44 Suppl 2

    Topics: Abortifacient Agents; Abortion, Induced; Abortion, Veterinary; Animals; Blood Pressure; Cabergoline; Cloprostenol; Dogs; Ergolines; Female; Pregnancy; Pregnancy Outcome; Pregnancy, Animal; Uterine Artery; Uterus

2009
Influence of progesterone withdrawal on pregnancy-related parameters during post-implantation early pregnancy loss.
    Reproduction in domestic animals = Zuchthygiene, 2009, Volume: 44 Suppl 2

    Topics: Abortion, Induced; Abortion, Veterinary; Animals; Cabergoline; Cloprostenol; Dogs; Embryonic Development; Ergolines; Estrenes; Female; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Relaxin

2009
Management of prolactinomas in Brazil: an electronic survey.
    Pituitary, 2010, Volume: 13, Issue:3

    Topics: Brazil; Bromocriptine; Cabergoline; Data Collection; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Prolactinoma

2010
[Galastop].
    Tijdschrift voor diergeneeskunde, 2009, Dec-15, Volume: 134, Issue:24

    Topics: Abortifacient Agents; Abortion, Veterinary; Animals; Cabergoline; Dogs; Ergolines; Female; Legislation, Veterinary; Netherlands; Pregnancy; Pregnancy, Animal; Ultrasonography, Prenatal

2009
Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:6

    Topics: Adult; Birth Weight; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Progesterone; Prolactin; Prolactinoma

2010
[Application of Pfizer drugs in the obstetrics and gynecology practice].
    Akusherstvo i ginekologiia, 2009, Volume: 48 Suppl 1

    Topics: Anti-Bacterial Agents; Antifungal Agents; Cabergoline; Carboprost; Clindamycin; Dopamine Agonists; Drug Combinations; Ergolines; Female; Fertility Agents, Female; Fluconazole; Genital Diseases, Female; Humans; Nafarelin; Pregnancy; Pregnancy Complications; Tromethamine

2009
Prevention of ovarian hyperstimulation syndrome in a rat model: efficacy comparison between cabergoline and meloxicam.
    Acta obstetricia et gynecologica Scandinavica, 2010, Volume: 89, Issue:5

    Topics: Analysis of Variance; Animals; Biopsy, Needle; Body Weight; Cabergoline; Chorionic Gonadotropin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Female; Immunohistochemistry; Injections, Intramuscular; Meloxicam; Organ Size; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Pregnancy; Pregnancy, Animal; Probability; Random Allocation; Rats; Rats, Wistar; Thiazines; Thiazoles; Vascular Endothelial Growth Factor A

2010
Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women.
    Clinical endocrinology, 2010, Volume: 73, Issue:2

    Topics: Adult; Antineoplastic Agents; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Prolactinoma; Retrospective Studies

2010
Comparison of cabergoline and bromocriptine in patients with asymptomatic incidental hyperprolactinemia undergoing ICSI-ET.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010, Volume: 26, Issue:7

    Topics: Adult; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Rate; Retrospective Studies; Sperm Injections, Intracytoplasmic; Treatment Outcome

2010
Prolactinomas and pregnancy.
    Clinical endocrinology, 2010, Volume: 73, Issue:2

    Topics: Aminoquinolines; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Embryonic Development; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma

2010
[Spontaneous ovarian hyperstimulation syndrome in a pregnancy with hypothyroidism].
    Gynecologie, obstetrique & fertilite, 2011, Volume: 39, Issue:3

    Topics: Abdominal Pain; Adrenal Cortex Hormones; Adult; Cabergoline; Chorionic Gonadotropin; Ergolines; Female; Fibrinolytic Agents; Follicle Stimulating Hormone; Gestational Age; Graves Disease; Humans; Hypothyroidism; Luteinizing Hormone; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Complications; Thyroidectomy; Thyrotropin

2011
[Prolactinoma treatment status in the cabergoline era].
    No shinkei geka. Neurological surgery, 2011, Volume: 39, Issue:11

    Topics: Adolescent; Adult; Aged; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Treatment Outcome

2011
Comparison of the use of cabergoline and gonadotrophin to treat primary and secondary anoestrus in bitches.
    Australian veterinary journal, 2012, Volume: 90, Issue:5

    Topics: Administration, Oral; Anestrus; Animals; Breeding; Cabergoline; Dogs; Dose-Response Relationship, Drug; Ergolines; Estrus; Female; Gonadotropins; Injections, Intramuscular; Ovulation Induction; Pregnancy; Pregnancy Rate

2012
[Gender effect on cardiomyopathy].
    Giornale italiano di cardiologia (2006), 2012, Volume: 13, Issue:6

    Topics: Bromocriptine; Cabergoline; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiomyopathy, Restrictive; Dopamine Agonists; Ergolines; Evidence-Based Medicine; Female; Genetic Counseling; Humans; Phenotype; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Prolactin; Risk Assessment; Risk Factors; Sex Factors; Treatment Outcome

2012
[Postpartum psychosis associated with cabergoline].
    Medicina clinica, 2013, Jan-05, Volume: 140, Issue:1

    Topics: Adult; Antipsychotic Agents; Cabergoline; Cesarean Section; Dopamine Agonists; Ergolines; Female; Hallucinations; Humans; Lactation; Postoperative Complications; Pregnancy; Pregnancy Complications; Pregnancy, Twin; Psychomotor Agitation; Psychotic Disorders; Puerperal Disorders; Risperidone; Sleep Initiation and Maintenance Disorders

2013
Cabergoline therapy for macroprolactinoma during pregnancy: a case report.
    BMC research notes, 2012, Oct-31, Volume: 5

    Topics: Adult; Antineoplastic Agents; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma

2012
Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation.
    The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:1

    Topics: Adult; Antineoplastic Agents; Breast Feeding; Cabergoline; Data Collection; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Lactation; Observation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Puerperal Disorders; Recurrence; Time Factors

2013
Successful treatment of a large macroprolactinoma with cabergoline during pregnancy.
    Pituitary, 2001, Volume: 4, Issue:3

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma

2001
Assessment of cabergoline as a reproductive inhibitor in coyotes (Canis latrans).
    Reproduction (Cambridge, England). Supplement, 2002, Volume: 60

    Topics: Abortifacient Agents, Steroidal; Administration, Oral; Animals; Animals, Zoo; Cabergoline; Carnivora; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Female; Litter Size; Male; Pregnancy; Progesterone; Prolactin; Time Factors

2002
Induction of abortion in queens by administration of cabergoline (Galastop) solely or in combination with the PGF2alpha analogue Alfaprostol (Gabbrostim).
    Theriogenology, 2004, Volume: 61, Issue:7-8

    Topics: Abortion, Induced; Abortion, Veterinary; Animals; Cabergoline; Cats; Ergolines; Female; Pregnancy; Progesterone; Prostaglandins F; Time Factors

2004
Dopamine agonist treatment before and after the birth reduces prolactin concentration but does not impair paternal responsiveness in Djungarian hamsters, Phodopus campbelli.
    Hormones and behavior, 2005, Volume: 47, Issue:3

    Topics: Animals; Bromocriptine; Cabergoline; Cricetinae; Dopamine Agonists; Ergolines; Female; Male; Parturition; Paternal Behavior; Phodopus; Pregnancy; Prolactin; Receptors, Dopamine D1; Receptors, Dopamine D2

2005
Morphology of canine placental sites after induced embryonic or fetal death.
    Theriogenology, 2006, Volume: 66, Issue:6-7

    Topics: Animals; Cabergoline; Cloprostenol; Dogs; Embryo Loss; Ergolines; Estrenes; Female; Fetal Death; Immunohistochemistry; Microscopy, Electron, Transmission; Placenta; Pregnancy

2006
[Case of juvenile parkinsonism in pregnancy].
    Rinsho shinkeigaku = Clinical neurology, 2006, Volume: 46, Issue:6

    Topics: Adult; Antiparkinson Agents; Benzothiazoles; Cabergoline; Carbidopa; Contraindications; Dopamine Agents; Dopamine Agonists; Ergolines; Family Planning Services; Female; Humans; Infant, Newborn; Levodopa; Parkinsonian Disorders; Pramipexole; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Thiazoles

2006
The effects of a low dose of cabergoline on induction of estrus and pregnancy rates in anestrous bitches.
    Animal reproduction science, 2007, Volume: 101, Issue:1-2

    Topics: Anestrus; Animals; Breeding; Cabergoline; Dogs; Dose-Response Relationship, Drug; Ergolines; Estrus; Female; Ovulation Induction; Pregnancy; Pregnancy Rate; Pregnancy, Animal

2007
Cabergoline treatment of pregnant women with macroprolactinomas.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007, Volume: 99, Issue:1

    Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Treatment Outcome

2007
Editorial: Preventing ovarian hyperstimulation syndrome.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:8

    Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Randomized Controlled Trials as Topic; Vascular Endothelial Growth Factor A

2007
Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study.
    Human reproduction (Oxford, England), 2007, Volume: 22, Issue:12

    Topics: Adult; Cabergoline; Dopamine Agonists; Embryo Implantation; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pilot Projects; Pregnancy; Pregnancy Rate; Reproductive Techniques, Assisted; Retrospective Studies

2007
Cabergoline: an advance in dopaminergic therapy.
    Clinical endocrinology, 1994, Volume: 41, Issue:6

    Topics: Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Patient Compliance; Pregnancy; Prolactin

1994
Cabergoline treated hyperprolactinaemia results in pregnancy in a bromocriptine intolerant patient after seventeen years of infertility.
    British journal of obstetrics and gynaecology, 1994, Volume: 101, Issue:4

    Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agents; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy

1994
Effectiveness of cabergoline in reducing follicle-stimulating hormone and prolactin hypersecretion from pituitary macroadenoma in an infertile woman.
    Fertility and sterility, 1994, Volume: 62, Issue:4

    Topics: Adenoma; Adult; Amenorrhea; Cabergoline; Dopamine Agonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactin

1994
Regulation of progesterone during pregnancy in the cat: studies on the roles of corpora lutea, placenta and prolactin secretion.
    Journal of reproduction and fertility. Supplement, 1993, Volume: 47

    Topics: Animals; Cabergoline; Cats; Corpus Luteum; Ergolines; Female; Megestrol; Megestrol Acetate; Ovariectomy; Placenta; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Pseudopregnancy

1993
Practical use of a combination of a dopamine agonist and a synthetic prostaglandin analogue to terminate unwanted pregnancy in dogs.
    The Journal of small animal practice, 1996, Volume: 37, Issue:5

    Topics: Abortion, Induced; Abortion, Veterinary; Administration, Oral; Animals; Cabergoline; Cloprostenol; Dogs; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Injections, Subcutaneous; Pregnancy; Pregnancy Outcome; Progesterone

1996
In vivo investigation of luteal function in dogs: effects of cabergoline, a dopamine agonist, and prolactin on progesterone secretion during mid-pregnancy and -diestrus.
    Domestic animal endocrinology, 1997, Volume: 14, Issue:1

    Topics: Animals; Cabergoline; Corpus Luteum; Diestrus; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Injections, Intravenous; Injections, Subcutaneous; Luteal Phase; Luteinizing Hormone; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Radioimmunoassay; Random Allocation; Time Factors

1997
Prevention and termination of pregnancy in rats by cabergoline, a dopamine agonist.
    Journal of reproduction and fertility, 1997, Volume: 109, Issue:1

    Topics: Animals; Cabergoline; Contraceptive Agents, Female; Dopamine Agonists; Embryo Implantation; Ergolines; Estradiol; Female; Male; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Rats; Rats, Sprague-Dawley

1997
Termination of dioestrus and induction of oestrus in dioestrous nonpregnant bitches by the prolactin antagonist cabergoline.
    Journal of reproduction and fertility. Supplement, 1997, Volume: 51

    Topics: Animals; Breeding; Cabergoline; Diestrus; Dogs; Dopamine Agonists; Ergolines; Estrus; Female; Infertility, Female; Pregnancy; Progesterone; Prolactin; Uterus; Vaginal Smears

1997
Termination of pregnancy in cats using a combination of cabergoline, a new dopamine agonist, and a synthetic PGF2 alpha, cloprostenol.
    Journal of reproduction and fertility. Supplement, 1997, Volume: 51

    Topics: Abortion, Induced; Administration, Oral; Animals; Cabergoline; Cats; Cloprostenol; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Female; Injections, Subcutaneous; Pregnancy; Progesterone

1997
Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.
    Journal of endocrinological investigation, 1997, Volume: 20, Issue:9

    Topics: Adenoma; Adolescent; Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Kinetics; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin

1997
[Administration of combination therapy with synthetic pgf2alpha analogs and a dopamine agonist for the termination of unwanted pregnancy in pregnant dogs. A study of six cases].
    Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere, 1998, Volume: 26, Issue:1

    Topics: Abortifacient Agents; Abortion, Induced; Animals; Cabergoline; Cloprostenol; Dinoprost; Dogs; Dopamine Agonists; Drug Therapy, Combination; Ergolines; Female; Injections, Subcutaneous; Pregnancy

1998
Effects of cabergoline on reproduction in three families of Australian marsupials.
    Journal of reproduction and fertility, 1998, Volume: 113, Issue:1

    Topics: Administration, Oral; Animals; Animals, Newborn; Body Weight; Cabergoline; Dopamine Agonists; Ergolines; Female; Injections, Intramuscular; Lactation; Macropodidae; Marsupialia; Pregnancy; Pregnancy, Animal; Prolactin; Reproduction

1998
[Cabergoline].
    Deutsche medizinische Wochenschrift (1946), 1998, Nov-06, Volume: 123, Issue:45

    Topics: Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Prolactin

1998
Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:7

    Topics: Adenoma; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Drug Tolerance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Retrospective Studies; Sex Characteristics

1999
Dopamine agonist therapy in hyperprolactinemia.
    The Journal of reproductive medicine, 1999, Volume: 44, Issue:12 Suppl

    Topics: Aminoquinolines; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pregnancy; Pregnancy Complications

1999
Effect of stage of anestrus on the induction of estrus by the dopamine agonist cabergoline in dogs.
    Theriogenology, 1999, Volume: 51, Issue:3

    Topics: Anestrus; Animals; Behavior, Animal; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Estradiol; Female; Fertility; Luteinizing Hormone; Male; Pregnancy; Progesterone; Prolactin; Vagina

1999
Cabergoline.
    Expert opinion on pharmacotherapy, 2000, Volume: 1, Issue:3

    Topics: Animals; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pregnancy

2000
Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome.
    Human reproduction (Oxford, England), 2001, Volume: 16, Issue:11

    Topics: Adult; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Infertility, Female; Ovarian Follicle; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Recombinant Proteins; Time Factors; Ultrasonography

2001
[Dostinex - the most effective medicine for inhibition of postpartal lactation].
    Akusherstvo i ginekologiia, 2001, Volume: 40, Issue:4

    Topics: Cabergoline; Dopamine Agents; Drug Administration Schedule; Ergolines; Female; Humans; Lactation; Pregnancy; Prolactin

2001
Use of cabergoline to treat primary and secondary anestrus in dogs.
    Journal of the American Veterinary Medical Association, 2002, Jun-01, Volume: 220, Issue:11

    Topics: Anestrus; Animals; Cabergoline; Dogs; Dopamine Agonists; Ergolines; Female; Fertility; Ovarian Follicle; Ovulation Induction; Pregnancy; Progesterone; Prospective Studies; Safety; Treatment Outcome; Vagina; Vaginal Smears

2002
Effects on pseudopregnancy, pregnancy and interoestrous intervals of pharmacological suppression of prolactin secretion in female dogs and cats.
    Journal of reproduction and fertility. Supplement, 1989, Volume: 39

    Topics: Abortion, Spontaneous; Animals; Birth Weight; Cabergoline; Cats; Dogs; Dose-Response Relationship, Drug; Ergolines; Estrus; Female; Lactation; Pregnancy; Pregnancy, Animal; Progesterone; Prolactin; Pseudopregnancy

1989
Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women.
    The Journal of clinical endocrinology and metabolism, 1987, Volume: 65, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Cabergoline; Delayed-Action Preparations; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Hyperprolactinemia; Menstrual Cycle; Middle Aged; Postpartum Period; Pregnancy; Prolactin; Receptors, Dopamine

1987